← Research library

Efficiency of Trekrezan in experimental bronchopneumonia in rats

Animal research · 2006

What was studied
Rats with experimental acute bronchopneumonia
Main finding
The abstract reports altered lymphocyte immune measures, lower lactate and higher ATP and pyruvate in lung tissue and blood lymphocytes.

Reported findings and study design

Rat acute-bronchopneumonia model; Trekrezan 25 mg/kg.

Population or model Rats with experimental acute bronchopneumonia

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Lactate/ADP/AMPLower values reported
Pyruvate/ATPHigher values reportedNo numerical concentrations supplied

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Preclinical disease model; no human pneumonia benefit established. Program overlap with later dissertation and review is possible.

Source details

Citation and available abstract or selected source passages checked; complete methods and risk-of-bias appraisal pending.

Sources checked

Citation

Animal / experimentalEnglish abstract

I. V. Zarubina, A. V. Bolekhan, P. D. Shabanov. Efficiency of Trekrezan in experimental bronchopneumonia in rats Bull Exp Biol Med 142(2):205–208

Study source ↗ · DOI 10.1007/s10517-006-0328-4 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards